May 2013 Vol. 8 No. 5

FDA approves Simponi for ulcerative colitis

May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe ulcerative colitis. Read more.

From your ANA President

Nurses are natural innovators. Let’s recognize our strengths as innovators and share our ideas on multiple platforms.

Health, safety, & wellness

Planned workplace napping can reduce error risk, increase productivity, and boost efficiency in healthcare workers.

Introducing the quantum patient

The quantum patient is an indivisible human being whose health problems might not be healed through traditional specialization.
self manage management brain

Issues up close Managing yourself

Learn to manage yourself before you try to lead anyone else. This was an important insight that 120 nurse managers in South Florida shared during interviews with our…

Readers Respond

Billing by nursing intensity: One way to ease understaffing? Re: “Hospital nurse staffing for dummies” (March 2013): Perhaps changing how nurses’ time is billed would help relieve understaffing.…

Study identifies barriers to patient safety

A study by AIG of hospital C-suite executives and risk managers in the United States found that the largest barrier to patient safety is lack of teamwork, negative…

The new normal

Welcome to fiscal austerity—the new normal.

Why disruption can be a good thing

Seventy-two seconds into liftoff, a defective mechanical part set off a string of events that caused the Challenger space shuttle to tear apart as millions watched it vanish…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.